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INTRODUCTION 
In a commentary in Vol. 20. No. 3, ofthis joumal, Ashby 
and Lcigibcl [ 19921 warned of possible confusion in the 
understanding of gcnotoxic and nongenotoxic carcinogens 
becausc thc ncw transgenic mutation assays might open thc 
possihility of dctecting mutagenic activitics of chemieals 
unrclated to their presence in the cell at the momcnt of 
mutation initiation. They reasoncd that carcinogcns ablc to 
stimulatc thc rate of ccll division I Buuerworth, 1990; Cohen 
and Ellwein, 19911 could aceeierate the accumulation of 
··spontancous'' mutations in marker genes arising from en-
dogenous DNA darnage IAmcs. 1989~ Loeb, 1989: Lutz. 
1990]. 
Wehave just completed a study to investigate whcther the 
measurement of lad mutations in lac/ transgenic mice 
1 Kohl er et al.. 1990 I could indccd be uscd to dctcct non-
genotoxic carcinogens such as heptachlor and phenobarbital 
as "indirect mutagens.'' following a 4-month feeding period 
at dosc Ievels positive in thc 2-yc:ar bioassays. Di(2-cthyl-
hcxyl)phthalatc (DEHP) was includcd in the study as a car-
cinogen that could, in addition to having mitogenic activity, 
be indirectly genotoxk via oxygen radicals from peroxis~­
mal hydrogen pcroxide. 2-Acctylaminotluorenc (2-AAI·) 
served as positive control for thc induction of lacl muta-
tions. Thc stimulation of Ii ver ccll divisionwas investigated 
in thc samc animals, using immunohistochemistry for bro-
modeoxyuridinc incorporatcd into DNA. 
The negative rcsults. hoth for lad mutations in Ii ver DNA 
and for the rate of hcpatocytc division. show that thc non-
gcnotoxic carcinogcns investigatcd do not givc risc tu a 
gencrally incrcascd Ievei or mutations or a sustained gencral 
increasc in thc rate of ccll division. 
MATERIALSAND METHODS 
Fernale 6-wcck old lad transgenic C57BL!6 micc (Big 
Bluc® from Stratagcnc. Taconic Farms, Germantown, NY) 
were randomizcd by weight into groups of threc. They were 
trcated for 120 days with di(2-ethylhexyl)phthalatc (DEHP). 
© 1993 Wiley-Liss, lnc. 
hcptachlor, or sodium phcnobarbital mixed into the diet at 
Ievels of 3.000 and 6.000, 10 and 20, and 250 and 500 
mg/kg feed, respcctively. 2-Acctylaminofluorene (2-AAF) 
at 75 and 150 mg/kg fecd was uscd as genotoxic positive 
control. Extracts of food pcllcts wcre checked with capillary 
gas chromatography for the carcinogen conccntrations. Lev-
els wcrc found to be within -20/+ 15% of the nominal 
valucs. 
On day 119. a 24-hr osmotic minipump (Alzct 2001D 
from Alza Corp .. Palo Alto, CA) containing 220 ~l.l bro-
modeoxyuridine solution (BrdU; 20 mg/ml) was subcutane-
ously implanted into each trcatcd mouse and three of thc 
controls. Twenty-four hours later. all animals were killcd. 
Thc largc Ii ver lohe was put into 4% formalin for thc immu-
nohistochcmical determination of BrdU incorporatcd into 
ON A (Dietrich and Swenberg. 1991 ), thc rcmaining Ii ver 
was shock frozen in liquid nitrogen and storcd at -7ooc. 
Isolation of DNA, packaging of thc Iambda vector (bearing 
the lad gcnc) into viablc bactcriophage Iambda particles, 
and analysis of plaqucs fnr lad mutants was pcr.formcd 
according to the Instruction Manual distributcd by Strata-
gene (La Jolla, CA 92037). On averagc, 106,000 plaques 
were counted pcr trcated animal, and 180,000 for thc con-
trols. Dose rcsponses were cvaluated by linear regrcssion of 
the data. Individualdose groups wcrc comparcd tu the con-
trols for an effect using the Dunnett t-tcst. 
RESULTS 
The average weight gain of thc animals was not affected 
by thc trcatmcnts. Implantation of the BrdU-minipump had 
no effect on the spontaneous mutation frcqucncy in thc livcr, 
which was 10 x 10-5 (z 4 x J0-5;avcragc ± I S.D. from 
three micc~ a pooled total of 55 mutants were detected in 
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fig. 1. Mutation frequencies in the lacl gene of liver DNA isolated from 
female lad Iransgeniemice 4 months after feeding with three nongenotoxic 
and one genotoxic hepatocarcinogen at two dose Ievels. Each spot repre-
sents one animal. On average, 180,000 and I 06,000 plaques were analyzed 
for each control and treated mause, respectively. Confidence intervals for 
the single values can be estimated from the Poisson distribution. Mean 
mutation frequencies are given in the text. 
54, 100 plaques analyzed). As expected, treatment with the 
genotoxic carcinogen 2-AAF resulted in a dose-dependent 
and highly significant increase of the mutation frequency to 
27 X J0-5 (±8 X J0- 5) and 51 X lO-s {±20 X 10-5) at 
75 and 150 ppm in the diet, respectively. 
With the nongenotoxic hepatocarcinogens, no significant 
increases in mutation frequency could be observed. The 
average mutation frequencies (n = 3; x 10- 5) were 17 ± 7 
and 12 ± 2 for DEHP, 25 ± 25 and 14 ± lO for heptachlor. 
and 12 ± 6 and 10 ± I for phenobarbital (low and high 
doses, respectively). The animal-to-animal variation in re-
sponse was quite marked with heptachlor. Figure 1 shows 
the mutation frequencies for all animals. It clearly illustrates 
the difference between the genotoxic carcinogen 2-AAF and 
the three nongenotoxic carcinogens, produced at dose levels 
that would have resulted in a similar liver tumor incidence 
with all four carcinogens. At the high-dose Ievels, for in-
stance, a net increase in Ii ver tu mors of 34, 67, and 52 
percent was reported for the nongenotoxic carcinogens 
DEHP [Ashby and Tennant, 1988], heptachlor [Ashby and 
Tennant, 1988}, and phenobarbital [Thorpe and Walker, 
1973], whereas 2-AAF induced a 41% increase after 2 years 
[Littlefield et al., 1980 J. 
At the time point examined. the rate of cell division in the 
liver was also unaffected by exposure to the nongenotoxic 
carcinogens. The labeHing index for the incorporation of 
BrdU into DNA (number of BrdU-positive hepatocytes di-
vided by the total number of hepatocytes), i.e., the fraction 
of hepatocytes in S-phase within a 24-hr period, was 0.3%, 
with no differences between the groups (data not shown) . 
DISCUSSION 
Our data indicate that the two cl~.ssic nongenotoxic car-
cinogens heptachlor and phenobarbital did not give rise to an 
increase in lacl mutations in the transgenic mice treated for4 
months. DEHP also produced no increase, supporting the 
idea that oxygen radical-induced DNA darnage and mutage-
nicity is unlikely tobe involved in its carcinogenicity [But-
terworth, 1987]. The idea expressed by Ashby and Leigibel 
[ 1992], based upon a plausible mechanistic hypothesis, 
could not be supported with our experiments. How can thef 
negative data be explained? 
Strain Differences? 
Carcinogenicity of phenobarbital in the liver of the male 
mouse has been shown to be strongly strain dependent. 
Males of the C57BL/6 strain were not responsive [Becker, 
1982]. Only two strains of female mice have been investi-
gated (CF-I positive [Ponomarkov and Tomatis, 1976]; 
BALB/c negative [Cavaliere et al., 1986]). No sex or strain 
difference has been found in the carcinogenicity of hep-
tachlor. DEHP was carcinogenic for both rats and mice. lt is 
unlikely that the mice used in this study would not have 
shown any increased liver tumor formation within 2 years, 
particu1ar1y in the heptachlor and DEHP groups. Neverthe-
less, for transgenic animal strains to become valid short-
term test systems for chemical carcinogenesis, a few long-
term studies will have tobe performed. Futureexperiments 
should be based on the recently available lacl transgenic 
B6C3Fl hybrid mause, for which a large carcinogenicity 
data base exists (NTP studies [Ashby and Tennant, 1988]). 
Nonsustained Mitogenic Effect 
The mitogenic effect öf nongenotoxic hepatocarcinogens 
can be very prominent at the beginning of a treatment but 
fades away upon adaptation [Melnick, 1992]. Our negative 
data support the understanding that mitogenesis by non-
genotoxic carcinogens is not a sustained effect upon the 
entire organ. This also means that measuring the average 
Stimulation of cell division might not be a reliable short-term 
test for nongenotoxic carcinogens. 
Delayed Cell Death 
The nongenotoxic carcinogens tested have tumor-promot-
ing activity in an initiation-promotion protocol, probably 
due to providing a growth advantage to initiated cells. 
Clonal expansion of these ce1ls is not necessarily based on 
an increased rate of cell division but could also be the result 
of a decreased rate of death of initiated cells, which would 
also give the cells moretime to take the next step in malig-
nant transformation. This process is not accompanied by a 
measurable increase in mutations i.n the whole organ. 
lacl as Marker Gene 
The hypothesis tested was that nongenotoxic carcinogens 
could provide a general mitogenic stimulus to the target 
tissue, thereby randomly accelerating the fixation of sponta-
neaus DNA darnage as mutations. The negative results indi-
cate that the mechanisms of nongenotoxic carcinogens are 
more subtle. The lacl gene is unrelated to the process of 
carcinogenesis. If the nongenotoxic carcinogens are selec-
tively expanding clones of cells that have undergone a muta-
tion in a gene involved in growth control (i.e., "initiated" 
cells), then the /acl gene would not be a sensitive marker for 
their detection. lt might be better to measure mutation fre-
quency directly in a proto-oncogene or tumor suppressor 
gene. Nonetheless, if the process is specific to isolated pre-
neoplastic clones of cells. looking at the entire liver will 
dilute the investigated effect. 
In conclusion, our data indicate that the measurement of 
rates of cell division or mutations in the liver as a whole is 
unlikely to generate data that accurately describe the process 
of hepatocarcinogenesis. The clonal nature of the process of 
carcinogenesis has to be taken into account. Rather than 
analyzing the tissue as a whole, we need to search for ways 
to selectively examine cells that have already moved along 
the path toward tumor forrnation. 
ACKNOWLEDGMENTS 
We thank Dr. Peter Schmid for the analysis of the animal 
feed for the Ievels of the carcinogens, Ms. Regula Candrian 
and Dr. Daniel Dietrich for their help with the minipump 
implantation and the immunohistochemistry, and Dr. Chris-
tian Sengstag for numerous tips with the molecular biology 
techniques. 
REFERENCES 
Ames BN ( 1989): Endogenous DNA darnage as related to cancer and 
aging. Mutat Res 214:41-46. 
Nongenotoxic Carcinogens and lacl Mutations 211 
Ashby J. Leigibel U ( 1992): Transgenie mouse mutation assays-potential 
for confusion of genotoxic and non-genotoxic carcinogenesis-a 
proposed solution. Environ Mol Mutagen 20:145-147. 
Ashby J. Tennant RW (1988): Chemical sttucture, Salmonella mutagenic-
ity and extent of carcinogenicity as indicators of genotoxic carcino-
genesis among ·222 chemieals tested in rodents by the U.S. NCII 
NTP. Mutat Res 204:17-115. 
Becker FF ( 1982): Morphological classification of mouse Ii ver tu mors 
based on biological characteristics. Cancer Res 42:3918-3923. 
Butterworth BE ( 1987): Genetic toxicology of di(2-ethylhexyl)phthalate. 
In Butterworth BE, Slaga TJ (eds): "Nongenotoxic Mechanisms in 
Carcinogenesis." Cold Spring Harbor, NY: Cold Spring Harbor 
Labaratory, pp 257-276. 
Butterworth BE ( 1990): Consideration of both genotoxic and nongenotoxic 
mechanisms in predicting carcinogenic potential. Mutat Res 
239:117-132. 
Cavatiere A, Bufalari A, Vitali R (1986): Carcinogenicity and cocarcinoge-
nicity test of phenobarbital sodium in adult BALB/c mice. Tumori 
72:125-128. 
Cohen SM, Eilwein LB ( 1991 ): Genetic errors. cell proliferation, and 
carcinogenesis. Cancer Res 51 :6493-6505. 
Dietrich DR, Swenberg JA ( 1991 ): The presence of alpha-2u-globulin is 
necessary for d-limonene promotion of male rat kidncy tumors. 
Cancer Res 51 :3512-3521. 
Kohler SW, Provos! GS, Kretz PL, Dycaico MJ, Sorge JA, Short JM 
(1990): Development of a short-term, in vivo mutagenesis assay: 
the effects of methylation on the recovery of a Iambda phage shuttle 
vector from Iransgenie mice. Nucleic Acids Res 18:3007-3013. 
Littlefield NA, Farmer JH, Gaylor DW (1980): Effects of dose and time in 
a long-tcrm, low-dose carcinogenic study. J Environ Pathol Toxicol 
3:17-34. 
Loeb LA ( 1989): Endogenous carcinogenesis: molecular oncology into the 
twenty-first century-Presidential address. Cancer Res 49:5489-
5496. 
Lutz WK ( 1990): Endogenaus genotoxic agents and processes as a basis of 
spontaneaus carcinogenesis. Mutat Res 238:287-295. 
Melnick RL ( 1992): Does chemically induced hepatocyte proliferation pre-
dict liver carcinogenesis? FASEB J 6:2698-2706. 
Ponomarkov V, Tomatis L ( 1976): The effect of long-tehn administration 
of phenobarbitone in CF-I mice. Cancer Lett 1:165-172. 
Thorpe E, Walker AlT (1973): The toxicology of dieldrin (HEOD*). II. 
Comparative long-term oral toxicity sturlies in mice with dieldrin. 
DDT, phenobarbitone. beta-BHC and gamma-BHC. Fd Cosmet 
Toxicol II :433-442. 
Accepted by -
J.P. O'Neill 
